FDA Investigator Cynthia A Palmer
Cynthia A Palmer has conducted inspections on 12 sites in 5 countries as of 14 Dec 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
12
Last Inspection Date:
14 Dec 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
India,
Japan,
Italy,
Malta
FDA Investigators that have inspected at least one site in common with Cynthia A Palmer:
Alice S Tsao,
Anastasia I Offordile,
Anita R Michael,
Anna Lazar,
Anthony C Warchut,
Arlene M Badillo,
Barbara J Rincon,
Bijoy Panicker,
Brandi L Garbutt,
Carl A Huffman, III,
Carla J Lundi,
Charles M Edwards,
Christina K Theodorou,
Craig D Zagata,
Daniel J Deciero,
Daniel J Min,
David A Oluwo,
Deborah J Parris,
Denise M Digiulio,
Don H Bark, PhD,
Farhana Khan,
Gayle S Lawson,
Geraldine D Sanders,
Ginger M Sykes,
Hala L Selby,
Hala Lj Whetstone,
Heika R Tait,
James M Mason,
Javier O Vega,
Jogy George,
Jose M Cayuela,
Jose Ohernandez Guzman,
Julianne C Mccullough,
Junho Pak,
Karen A Briggs,
Kendra L Brooks,
Kham Phommachanh,
Khoa Nathanv Tran,
Ko U Min,
Lance Mde Souza, MBA,
Latorie S Jones,
LCDR Margaret Edi Gennaro,
Linda M Hoover,
Lisa M Bellows,
Luis A Dasta,
Luis Mburgos Medero,
Marcellinus D Dordunoo,
Margaret Faulkner,
Maria A Reed,
Marie F Morin,
Matthew R Noonan,
Maureen A Wentzel,
Meena Bansal Gupta, PhD,
Michael L Casner,
Michael R Goga,
Michael R Klapal,
Michele Gottshall,
Monika Borkowska,
Mra Greenc,
Mra Mcculloughj,
Nicholas A Violand,
Pal S Mayasandra,
Patrick C Klotzbuecher,
Qin Xu,
Reba A Gates,
Roger F Zabinski,
Saied A Asbagh,
Saleem A Akhtar,
Sam Pepe,
Sarah M Meng,
Sarah M Napier,
Seth J Goldenberg,
Shirley J Berryman,
Stacey S Degarmo,
Stephen J Koniers,
Susan D Yuscius,
Susan F Laska, MS,
Syeda N Mahazabin,
Tamil Arasu, PhD,
Thomas J Arista,
Tiffani D Wilson,
Todd J Maushart,
Vlada Matusovsky,
Yvesna C Blaise
Cynthia A Palmer's Documents
Publish Date | Document Type | Title |
---|---|---|
December, 2011 | FDA 483 | Sigmapharm Laboratories, LLC - Form 483, 2011-12-22 |
August, 2009 | FDA 483 | KVK-TECH, INC - Form 483, 2009-08-31 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more